tesamorelin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-02-25 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
An even older naming system for metal cations, also still widely used, appended the suffixes -ous and -ic to the Latin root of the name, to give special names for the low and high oxidation states. For example, this scheme uses "ferrous" and "ferric", for iron(II) and iron(III) respectively, so the examples given above were classically named ferrous sulfate and ferric sulfate. Common salt-forming cations include:
A newly developed ELISA system utilises genetically modified citrullinated vimentin (MCV), a naturally occurring isoform of vimentin to optimize the performance of the test. Noteworthy are the findings of a recently published study that highly valuates anti-MCV test systems for diagnosing rheumatoid arthritis in anti-CCP-negative patients. However, data from all around the world vary substantially. Anti-CCP is also very useful in the early diagnosis of rheumatoid arthritis in high-risk groups, such as relatives of RA patients, although Silman and co-workers found that the concordance rate of developing RA was 15.4% among identical (monozygotic) twins and was 3.6% among fraternal (dizygotic) twins. Given that ACPA are more specific than rheumatoid factor, they are used to distinguish various causes of arthritis. Novel assays may be useful for monitoring disease activity and effects of RA therapy. The reference ranges for blood tests of anti–citrullinated protein antibodies are:
Prior to that, at a rally in Alor Setar, he had similarly urged Anwar to step down, citing mismanagement of national wealth and poor governance. In December 2025, Mahathir lodged a police report accusing Anwar of economic sabotage and undermining Malaysia's sovereignty over the Malaysia–United States Agreement on Reciprocal Trade (ART), an agreement that later sparked public controversy over provisions seen by critics as obliging Malaysia to align with US sanctions, compromise regulatory autonomy, and weaken the country's long-standing policy of non-alignment. In early January 2026, Mahathir was admitted to the National Heart Institute (IJN) for observation after he fell at his residence and was taken to hospital by ambulance. Hospital officials later confirmed that he had sustained a fracture to his right hip and remained in stable condition while receiving treatment. According to his son, Mukhriz Mahathir, medical specialists advised that he was not suitable for hip replacement surgery due to age-related risks, and that a non-surgical recovery approach would be adopted. Mahathir's hospitalisation attracted significant domestic and international attention, with Turkish President Recep Tayyip Erdoğan conveying his concern and well wishes during a meeting with Prime Minister Anwar Ibrahim while the latter was on an official visit to Turkey. On 29 September, the day after his wife Siti Hasmah died, Mahathir was hospitalized at the National Heart Institute in Kuala Lumpur.
THC (Delta-9 tetrahydrocannabinol), the active component in cannabis. methamphetamine, also known as "ice", "crystal" and "crank". MDMA (Methylenedioxymethamphetamine), which is known as ecstasy. In February 2016 a New South Wales magistrate "acquitted a man who tested positive for cannabis". He had been arrested and charged after testing positive during a roadside drug test, despite not having smoked for nine days. He was relying on advice previously given to him by police.
Sources: en.wikipedia.org
=== Writing === Many central plot elements existed before designer Brian Mitsoda's involvement: the prince, the anarchs being upset, aspects of the Gehenna storyline, and Jack and the sarcophagus as a major subplot. The designers broadly tied the overarching story into each hub and level. Each designer controlled their assigned section of the game and worked with a small team, enabling quick decision-making and ease in keeping plot elements consistent. Mitsoda became the primary writer for many of the characters and their quests, dialog, and side content in the game, such as emails, which helped retain a consistent narrative. He was given freedom with respect to the script, with no restrictions on language or content, and could rewrite characters when he thought his initial draft was weak. Although Troika developed the story, it is inspired by White Wolf's Time of Judgment novels about a vampire apocalypse. Bloodlines' story was accepted as canonical by White Wolf, with the game serving as a prequel to Time of Judgment and including characters from the White Wolf game, such as Jack. Discussing character design, Mitsoda said he tried to disguise the need for characters who point a player in an appropriate direction:
For example, in the chemical structure of canagliflozin, a fluorine atom is connected to an aromatic ring, making the compound more stable and reducing the metabolism of the compound. Empagliflozin contains a tetrahydrofuran ring but not canagliflozin nor dapagliflozin.
Metabolic intermediates are compounds produced during the conversion of substrates (starting molecules) into final products in biochemical reactions within cells. Although these intermediates are of relatively minor direct importance to cellular function, they can play important roles in the allosteric regulation of enzymes, glycolysis, the citric acid cycle, and amino acid synthesis. Metabolic pathways consist of a series of enzymatically catalyzed reactions where each step transforms a substrate into a product that serves as the substrate for the next reaction. Metabolic intermediates are compounds that form during these steps, and they are neither the starting substrate nor the final product of the pathway. These intermediates are crucial because they allow for regulation, energy storage, and extraction of chemical energy in a controlled manner.
On October 17, 1952, Giáp launched attacks against the French garrisons along Nghĩa Lộ, northwest of Hanoi, and overran much of the Black River valley, except for the airfield of Nà Sản where a strong French garrison entrenched. Giáp by now had control over most of Tonkin beyond the De Lattre Line. Raoul Salan, seeing the situation as critical, launched Operation Lorraine along the Clear River to force Giáp to relieve pressure on the Nghĩa Lộ outposts. On October 29, 1952, in the largest operation in Indochina to date, 30,000 French Union soldiers moved out from the De Lattre Line to attack the Việt Minh supply dumps at Phú Yên. Salan took Phú Thọ on November 5, and Phu Doan on November 9 by a parachute drop, and finally Phú Yên on November 13. Giáp at first did not react to the French offensive. He planned to wait until their supply lines were overextended and then cut them off from the Red River Delta. Salan correctly guessed what the Việt Minh were up to and cancelled the operation on November 14, beginning to withdraw back to the De Lattre Line. The only major fighting during the operation came during the withdrawal, when the Việt Minh ambushed the French column at Chan Muong on November 17. The road was cleared after a bayonet charge by the Indochinese March Battalion, and the withdrawal could continue. The French lost around 1,200 men during the whole operation, most of them during the Chan Muong ambush. The operation was partially successful, proving that the French could strike out at targets outside the De Lattre Line.
Alternative splicing of intron 9 creates the β and γ isoforms with altered C-termini. An internal promoter in intron 4 produces the ∆133 and ∆160 isoforms, which lack part of the TAD and DBD. Alternative translation initiation at codons 40 or 160 results in ∆40p53 and ∆160p53 isoforms, respectively.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.